Objective:

To explore the benefits of preservative-free compounded formulations in glaucoma treatment, focusing on improving tolerability, adherence, affordability, and overall patient quality of life.

Key Findings:

• Preservative-free compounded drops improve patient comfort and adherence by reducing ocular surface irritation, as evidenced by patient-reported outcomes.
• These formulations are cost-effective, especially for patients with financial constraints or insurance limitations, leading to improved access to necessary treatments.
• Compounded drops simplify treatment regimens, reducing the number of medications and administration frequency, which enhances patient compliance.

Interpretation:

Integrating preservative-free compounded drops into glaucoma treatment can enhance patient quality of life and treatment adherence while minimizing side effects and financial burdens, as supported by the key findings.

Limitations:

• Not all patients may prefer compounded drops, with some opting for traditional options, which could limit the applicability of these findings.
• Availability of compounded formulations may vary by region and pharmacy, potentially affecting patient access and treatment consistency.

Conclusion:

Preservative-free compounded glaucoma drops represent a practical solution to common treatment barriers, promoting better patient outcomes and satisfaction.